Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...

Type I interferon (IFN) score may effectively predict disease progression in limited cutaneous systemic sclerosis, with a ...

The odds of developing systemic lupus erythematosus or systemic sclerosis appear to significantly increase with the use of ...